HomeOracleCVE-2026-21974

CVE-2026-21974

MEDIUM
5.3CVSS
Published: 2026-01-20
Updated: 2026-01-29
AI Analysis

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVSS Metrics

Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Attack Vector
network
Complexity
low
Privileges
none
User Action
none
Scope
unchanged
Confidentiality
low
Integrity
none
Availability
none
Weaknesses
CWE-200

Metadata

Primary Vendor
ORACLE
Published
1/20/2026
Last Modified
1/29/2026
Source
NIST NVD
Note: Verify all details with official vendor sources before applying patches.

Affected Products

oracle : life_sciences_central_designer

AI-Powered Remediation

Generate remediation guidance or a C-suite brief for this vulnerability.

Executive Intelligence Brief

CVE-CVE-2026-21974 | MEDIUM Severity | CVEDatabase.com | CVEDatabase.com